Evaro

Investor: AlbionVC

Evaro, an NHS-licensed digital healthcare platform based in Norwich, has successfully secured £18 million in a Series A funding round. This investment, led by AlbionVC, will fuel the expansion of its 'healthcare-as-a-service' model, which provides embeddable digital pharmacy infrastructure and prescribing tools to consumer brands, healthcare providers, and employers.Summary of transaction details:Value: £18,000,000Sector: Digital Health, Healthcare-as-a-ServiceAdvisor: Not mentionedKey Entities: Target: Evaro; Lead Investor: AlbionVC; Other Investors: Simplyhealth Ventures, Exceptional Ventures, Cornerstone VC, BBILocation: Norwich, UKNote: This funding round underscores the increasing investor confidence in digital health platforms that offer scalable solutions to improve healthcare accessibility and reduce strain on traditional medical services. Evaro's robust regulatory compliance and established infrastructure are seen as key differentiators enabling its partners to safely enter the healthcare space and meet latent demand.

Investor: Syndicate Room, Exceptional Ventures, the University of East Anglia, Cornerstone VC